Effect of Transcutaneous Tibial Nerve Stimulation on Primary Dysmenorrhea

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-35
SponsorCairo University

About this trial

This study will be conducted to evaluate the effect of Transcutaneous Tibial Nerve Stimulation (TTNS) on primary dysmenorrhea.

Eligibility criteria

Qualifiers

Females with a regular menstrual cycle, experiencing primary dysmenorrhea, confirmed by history and clinical diagnosis.

Females aged between 18 and 35 years.

Their BMI ranging from 20 to 29.9 kg/m².

Disqualifiers

Females engaging in regular physical exercises prior to the study course.

A history of abdominal or pelvic surgery.

Pelvic pathologies or diseases (e.g., polycystic ovary syndrome, endometriosis, adenomyomas, or uterine fibroids).

Malignant or benign neoplasms in the uterus.

Trial design

Treatments tested in this trial

  • Standard physical therapy program
  • Transcutaneous Tibial Nerve Stimulation (TTNS)

Treatment groups

36 Participants
are divided into 2 treatment groups

Sponsors and collaborators